ILIANA MICALI: Open Payments
NPI 1134128788 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,908 in 63 payments from 20 companies in 2025. Trend: 2023 $1,579 · 2024 $1,836 · 2025 $2,908
Food & beverage: $2,747Education: $111Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $436 |
| AstraZeneca Pharmaceuticals LP | 8 | $393 |
| Corcept Therapeutics | 8 | $384 |
| Amgen Inc. | 6 | $322 |
| Novo Nordisk Inc | 5 | $217 |
| Teva Pharmaceuticals USA, Inc. | 4 | $180 |
| Phathom Pharmaceuticals, Inc. | 2 | $179 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $174 |
| Janssen Pharmaceuticals, Inc | 3 | $169 |
| ABBVIE INC. | 4 | $89 |
Products named: Korlym, JARDIANCE, REPATHA, AIRSUPRA, BREZTRI, VOQUEZNA, Kerendia, SPRAVATO.
Industry payments across WA — which companies pay providers there.
